Myths vs facts: ACTN3 and longevity

ACTN3 (alpha-actinin-3) is a gene primarily known for its role in muscle fiber composition. The common R577X variant leads to ACTN3 deficiency in X-allele carriers, which is associated with enhanced endurance performance. The myth that ACTN3 directly determines longevity is not supported by robust evidence. Some studies, particularly in older cohorts (e.g., Japanese centenarians), have reported a slightly higher frequency of the XX genotype, suggesting a possible metabolic advantage such as reduced muscle mass and lower energy expenditure. However, these associations are weak, not consistently replicated, and likely confounded by other genetic and lifestyle factors. Longevity is a polygenic trait influenced by hundreds of genes, environment, diet, and lifestyle. ACTN3 alone has no clinically meaningful predictive value. The evidence is based on population-level GWAS and mechanistic hypotheses, not on interventional trials. Consumers should be cautious of direct-to-consumer tests that market ACTN3 as a 'longevity gene' – such claims oversimplify the biology. A balanced diet, regular exercise, and avoiding smoking remain far more impactful for lifespan.